Dividends CalendarEarnings Calendar

MRSN | Mersana Therapeutics, Inc.

Mersana Therapeutics, Inc.

Company profile

  • Industry: Biotechnology
  • Sector: Healthcare
  • Headquarters:   Massachusetts, United States
  • Number of employees::   86

Company profile

Mersana Therapeutics is a clinical-stage biopharmaceutical company using its differentiated and proprietary ADC platforms to rapidly develop novel ADCs with optimal efficacy, safety and tolerability to meaningfully improve the lives of people fighting cancer. Mersana’s lead product candidate, XMT-1536, is in a Phase 1 proof-of-concept clinical trial in patients with tumors likely to express NaPi2b, including ovarian cancer and NSCLC adenocarcinoma. XMT-1592, Mersana’s second ADC product candidate targeting NaPi2b-expressing tumors, was created using Mersana’s customizable and homogeneous Dolasynthen platform and is in the dose escalation portion of a Phase 1 proof-of-concept clinical study. The Company’s early stage programs include a B7-H4 targeting ADC, as well as a STING-agonist ADC developed using the Company’s Immunosynthen platform. In addition, multiple partners are using Mersana’s Dolaflexin platform to advance their ADC pipelines.

    Address

    840 Memorial Drive
    Cambridge, MA 02139
    United States

      Key Persons / Board of Directors

      • CEO :  Anna Protopapas
      • CFO :  David A. Spellman


      Jump to (Finance sites)

      Their Official Profiles 

      Twitter

      Other stocks 

      snap csco cx fb lb jpm cag mtb kr hlt veev ntnx 

      Support this project

      If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
      More features coming soon :)

      Social Media 




      Recommended Books

      Investing For Dummies
      Buy on Amazon

      In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.